• World News
  • Politics
  • Stock
  • Investing
  • Editor’s Pick
Time And Sales Reporter
Investing

Lobe Sciences Ltd. to Attend the ArcStone-Kingswood Growth Summit 2025 in Toronto

by admin September 16, 2025
September 16, 2025

lobe sciences ltd. (CSE: LOBE,OTC:LOBEF) (OTCQB: LOBEF) (FSE: LOBE.F) (‘Lobe Sciences’ or the ‘Company’) a clinical stage biopharmaceutical company focused on developing products to treat diseases with significant unmet medical needs is pleased to announce its participation in the upcoming ArcStone-Kingswood Growth Summit in Toronto, taking place at the St. Regis Toronto on September 18, 2025. Dr. Frederick D Sancilio, CEO of lobe sciences ltd. will be presenting the company’s recent milestones and future growth strategy.

The ArcStone-Kingswood Growth Summit will be hosting over 20 companies and a curated group of investors for a full day of pre-arranged, targeted 1-on-1 meetings, panel discussions and networking opportunities.

Alongside the schedule of pre-booked meetings matching investors with appropriate projects, the conference program will provide amble opportunities to mix and mingle with the industry professionals and catch up on key industry developments.

Interested investors who would like to attend the ArcStone-Kingswood Growth Summit can register to request for a free invitation here.

About ArcStone Securities and Investments Corp.

ArcStone Securities and Investments Corp. is a diversified financial services firm with offices in Toronto and New York. Our firm specializes in providing bespoke solutions to mid-market companies worldwide, with a particular focus on cross-border transactions between Canada and the United States. Our partnership with Kingswood US enhances our ability to offer a full spectrum of financial services to our clients.

About Kingswood US

Kingswood US is a mid-market investment bank with a strong retail equity capital markets franchise and deep-rooted investment bank. The firm is dedicated to providing comprehensive financial services, including investment banking, wealth management, and capital raising, to clients across the United States.

About lobe sciences ltd.

Lobe Sciences Ltd. is a clinical stage biopharmaceutical company focused on developing novel therapies for rare neurological and hematological conditions. The company operates through two subsidiaries:

  • Altemia, Inc. is addressing sickle cell disease with two complementary assets: a medical food currently in early-stage distribution, and S-100, a patent-pending therapeutic candidate designed to treat the underlying pathology of the disease.

Lobe’s pipeline is differentiated by intellectual property, clinical momentum, and a strategic focus on high-value, underserved markets.

For additional Information, please contact:

lobe sciences ltd.
info@lobesciences.com
www.lobesciences.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/265683

News Provided by Newsfile via QuoteMedia

This post appeared first on investingnews.com

previous post
Angkor Resources: Unlocking Cambodia’s Resource Potential through Energy and Minerals Assets
next post
Pentagon calls Charlie Kirk posts ‘domestic terrorism’; Dem warns discipline is ‘un-American’

Related Posts

Biotech and Pharma Market Update: Q3 2025 in...

October 27, 2025

Cartier Resources

October 27, 2025

Aurum hits 0.8m @ 350 g/t gold at...

October 27, 2025

Crypto Market Update: Trump Pardons Binance Founder, Wall...

October 27, 2025

Cobalt Market Update: Q3 2025 in Review

October 27, 2025

Shaakichiuwaanaan Project Set to Become Second Largest Lithium...

October 25, 2025







    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.




    Recent Posts

    • The 5 longest government shutdowns in history: What happened, how they ended

      October 27, 2025
    • Trump dances with Malaysian performers as he kicks off Asia tour in lively fashion

      October 27, 2025
    • Swalwell demands 2028 Dem candidates vow to destroy Trump’s White House ballroom project

      October 27, 2025
    • PHOTOS: The making of Trump’s White House ballroom, a look at the construction progress

      October 27, 2025
    • Milei scores historic win in Argentina midterms, tightens grip on Congress

      October 27, 2025
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 timeandsalesreporter.com | All Rights Reserved

    Time And Sales Reporter
    • World News
    • Politics
    • Stock
    • Investing
    • Editor’s Pick

    Read alsox

    Uranium Stocks: 5 Biggest Companies in 2025

    May 20, 2025

    Crypto Market Recap: Stablecoin Market Makes Headway, SharpLink...

    June 14, 2025

    Why So Much Public Land?

    February 20, 2025